Current technical overviews of sentinel lymph node biopsy for breast cancer.
Current technical overviews of sentinel lymph node biopsy for breast cancer.
复制标题
DOI：
10.2325/jbcs.14.354
复制
发表时间：
2007-01-01
期刊：
影响因子：
--
通讯作者：
Sato, Kazuhiko
中科院分区：
文献类型：
--
作者：
Sato, Kazuhiko
前哨淋巴结活检 (SLNB) 基于前哨淋巴结 (SLN) 反映淋巴结状态的假设，SLN 阴性可能可以避免完全腋窝淋巴结清扫 (ALND)。尽管生存结果仍未知，但该技术已成为乳腺癌患者的护理标准。然而，讨论当前的技术和一些争议仍然很重要。本文回顾了各种 SLNB 技术的这些问题。
Sentinel lymph node biopsy (SLNB) is based on the hypothesis that the sentinel lymph node (SLN) reflects the lymph-node status and a negative SLN might allow complete axillary lymph node dissection (ALND) to be avoided. Although the survival outcome is still unknown, this technique has already become a standard of care for breast cancer patients. However, it is still important to discuss current techniques and some controversies. This article reviews these issues for a variety of SLNB techniques.